연구성과로 돌아가기

2024 연구자 정보 (467 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Lu, Yen-Shen
(Lu, YS) ⓘ 		Natl Taiwan Univ Hosp, Taipei, Taiwan ⓘ AAO-4015-2020
Shen, Yuchen ⓘ 		0000-0001-7461-1291
Lu, Yen-Shen ⓘ 		[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ tsurutaj@med.showa-u.ac.jp; ⓘ
Modi, Shanu
(Modi, S) ⓘ 		Mem Sloan Kettering Canc Ctr, New York, NY USA ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ tsurutaj@med.showa-u.ac.jp; ⓘ
Moon, Da Ru Chi
(Moon, DC) ⓘ 		Nune Eye Hosp, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Case report: Management of recurrent pupillary optic capture with sutureless surgical technique using 7-0 polypropylene flange ⓘ SCIE ⓘ 18.2 MEDICINE, GENERAL & INTERNAL ⓘ doojr@hanmail.net; ⓘ
Moon, Min Kyong
(Moon, MK) ⓘ 		제1저자 Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
SMG SNU Boramae Med Ctr, Dept Internal Med, Seoul, South Korea ⓘ 		J-5466-2012
Moon, Min ⓘ
ⓘ 		[JCR상위 18.2] The clinical course of hospitalized COVID-19 patients and aggravation risk prediction models: a retrospective, multi-center Korean cohort study ⓘ SCIE ⓘ 18.2 MEDICINE, GENERAL & INTERNAL ⓘ ksw2kms@knu.ac.kr;tspark@stats.snu.ac.kr; ⓘ
Niikura, Naoki
(Niikura, N) ⓘ 		Tokai Univ, Sch Med Hosp, Hiratsuka, Kanagawa, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ tsurutaj@med.showa-u.ac.jp; ⓘ
Nishijima, Soichiro
(Nishijima, S) ⓘ 		Daiichi Sankyo Co Ltd, Tokyo, Japan ⓘ KVA-8556-2024
Nishijima, Soichiro ⓘ 		0009-0003-7079-2883
Nishijima, Soichiro ⓘ 		[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ tsurutaj@med.showa-u.ac.jp; ⓘ
Nishiyama, Yuji
(Nishiyama, Y) ⓘ 		Daiichi Sankyo Co Ltd, Tokyo, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ tsurutaj@med.showa-u.ac.jp; ⓘ
Oh, Bumjo
(Oh, B) ⓘ 		Seoul Natl Univ, Dept Family Med, Coll Med, Seoul, South Korea
SMG SNU Boramae Med Ctr, Dept Family Med, Seoul, South Korea ⓘ 		GWN-2776-2022
Oh, Bumjo ⓘ
ⓘ 		[JCR상위 18.2] The clinical course of hospitalized COVID-19 patients and aggravation risk prediction models: a retrospective, multi-center Korean cohort study ⓘ SCIE ⓘ 18.2 MEDICINE, GENERAL & INTERNAL ⓘ ksw2kms@knu.ac.kr;tspark@stats.snu.ac.kr; ⓘ
Ohi, Yasuyo
(Ohi, Y) ⓘ 		Hakuaikai Social Med Corp, Sagara Hosp, Dept Pathol, Kagoshima, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ mjkwon94@knu.ac.kr;yas794@mail.harvard.edu; ⓘ
Rai, Yoshiaki
(Rai, Y) ⓘ 		Hakuaikai Social Med Corp, Sagara Hosp, Dept Breast & Endocrine Surg Oncol, 3-28 Matsubara, Kagoshima 8920098, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ mjkwon94@knu.ac.kr;yas794@mail.harvard.edu; ⓘ
Sagara, Yasuaki
(Sagara, Y) ⓘ 		교신저자 Hakuaikai Social Med Corp, Sagara Hosp, Dept Breast & Endocrine Surg Oncol, 3-28 Matsubara, Kagoshima 8920098, Japan ⓘ AAE-3747-2020
Sagara, Yasuaki ⓘ
ⓘ 		[JCR상위 18.2] Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ mjkwon94@knu.ac.kr;yas794@mail.harvard.edu; ⓘ
Sagara, Yoshiaki
(Sagara, Y) ⓘ 		교신저자 Hakuaikai Social Med Corp, Dept Radiol, Sagara Hosp, Kagoshima, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ mjkwon94@knu.ac.kr;yas794@mail.harvard.edu; ⓘ
Said-Al Ahl, Hussein A. H.
(Ahl, HAHSA) ⓘ 		교신저자 Natl Res Ctr NRC, Pharmaceut & Drug Ind Res Inst, Med & Aromat Plants Res Dept, 33 El Behouth St, Giza 12622, Egypt ⓘ F-6815-2018
Ahl, Hussein ⓘ
ⓘ 		[JCR상위 18.2] Comparative Effects of Calcium, Boron, and Zinc Inhibiting Physiological Disorders, Improving Yield and Quality of Solanum lycopersicum ⓘ SCIE ⓘ 18.2 BIOLOGY ⓘ haleema_12@yahoo.co.in;dr.syedtanveershah@hu.edu.pk;abdulbasit97_lily@knu.ac.kr;wafaahikal@gmail.com;marifkhan75@aup.edu.pk;waleedkhan.my@gmail.com;shussein272@yahoo.com;mudauf@ukzn.ac.za; ⓘ
Sato, Mutsumi
(Sato, M) ⓘ 		Hakuaikai Social Med Corp, Sagara Hosp, Dept Breast & Endocrine Surg Oncol, 3-28 Matsubara, Kagoshima 8920098, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 18.2] Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ mjkwon94@knu.ac.kr;yas794@mail.harvard.edu; ⓘ
Sohn, Joo Hyuk
(Sohn, JH) ⓘ 		Yonsei Univ Hlth Syst, Seoul, South Korea ⓘ
ⓘ 		0000-0002-2303-2764
Sohn, Joohyuk ⓘ 		[JCR상위 18.2] Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study ⓘ SCIE ⓘ 18.2 OBSTETRICS & GYNECOLOGY;ONCOLOGY ⓘ tsurutaj@med.showa-u.ac.jp; ⓘ
페이지 이동: